Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Order of PMC and PEG-Asc for Bowel Preparation
NCT02979223Phase 2Completed
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Start
- Nov 2016
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised trial of sodium picosulfate, magnesium, macrogol and ascorbic acid in bowel preparation (2 arms), sponsored by Cancer Institute and Hospital, Chinese Academy of Medical Sciences. Primary endpoint: Successful bowel preparation (Excellent and Good in Aronchick bowel preparation score). Started Nov 2016; status: completed.
02
Drugs
sodium picosulfatemagnesiummacrogolascorbic acid
03
Conditions
bowel preparation
Beyond the preview
Go deeper on NCT02979223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02979223.